732 studies found for:    "Esophageal Neoplasms"
Show Display Options
Rank Status Study
1 Completed Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Cancer of the Esophagus;   Esophagus Cancer;   Esophageal Neoplasm;   Cancer of Esophagus
Interventions: Drug: Irinotecan (drug);   Drug: Taxotere (drug);   Procedure: Radiotherapy (procedure);   Procedure: Esophagectomy (procedure)
2 Recruiting Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
Conditions: Esophageal Neoplasm;   Esophageal Cancer TNM Staging Primary Tumor (T) T2;   Esophageal Cancer TNM Staging Primary Tumor (T) T3;   Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0;   Esophageal Cancer TNM Staging Distal Metastasis (M) M0
Intervention: Radiation: Prophylactic postoperative radiation therapy
3 Active, not recruiting Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Capecitabine (Xeloda)
4 Terminated Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: CD40 Ligand Gene (AdcuCD40L)
5 Completed
Has Results
Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial
Condition: Esophageal Neoplasm
Interventions: Other: Restrictive group;   Other: Liberal group
6 Terminated Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: AdcuCD40L
7 Completed Outcomes After Esophageal Cancer Surgery
Conditions: Esophageal Neoplasm;   Esophageal Disease
Intervention: Procedure: Esophagectomy
8 Terminated Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
Conditions: Esophageal Neoplasms;   Carcinoma, Squamous Cell;   Adenocarcinoma;   Esophageal Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: [18-F] Fluorodeoxyglucose (FDG);   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin
9 Unknown  Docetaxel and S-1 for Advanced Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: DS (docetaxel+S-1)
10 Terminated Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
Conditions: Barrett Esophagus;   Esophageal Neoplasms;   Deglutition Disorders;   GERD;   Neoplasm
Interventions: Device: CSA System (CryoSpray AblationTM System);   Device: CryoSpray Ablation
11 Terminated A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Procedure: Esophagectomy
12 Completed Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Recurrent Esophageal Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage III Esophageal Cancer;   Stage IV Esophageal Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
13 Recruiting Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
Condition: Esophageal Neoplasms
Interventions: Other: Preoperative treatment of chemotherapy and radiation;   Other: Postoperative treatment of chemotherapy and radiation
14 Unknown  PET-CT Based Radiotherapy in Esophageal Cancer Patients
Condition: Esophageal Neoplasms
Intervention:
15 Active, not recruiting Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Adenocarcinoma of the Stomach;   Squamous Cell Carcinoma of the Esophagus;   Stage II Esophageal Cancer;   Stage II Gastric Cancer;   Stage III Esophageal Cancer;   Stage III Gastric Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: oxaliplatin;   Drug: fluorouracil;   Radiation: radiation therapy;   Procedure: conventional surgery;   Other: immunohistochemistry staining method;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: laboratory biomarker analysis;   Genetic: gene expression analysis;   Radiation: fludeoxyglucose F 18
16 Withdrawn Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy
Condition: Esophageal Carcinoma
Intervention: Drug: Bevacizumab, cetuximab
17 Recruiting Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer
Conditions: Surgical Procedures;   Minimally Invasive;   Operative;   Esophageal Neoplasms;   Cancer of Esophagus;   Esophagectomy
Interventions: Procedure: Ivor Lewis;   Procedure: Tri-incision
18 Recruiting Comparable Study of Different Radiation Dose in Esophageal Carcinoma
Condition: Esophageal Carcinoma
Interventions: Radiation: intensity modulated radiation therapy in both arms;   Drug: concurrent chemotherapy with radiation
19 Recruiting Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma
Condition: Esophageal Carcinoma
Intervention: Drug: Pertuzumab, trastuzumab
20 Completed Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.
Condition: Esophageal Carcinoma
Interventions: Drug: Cisplatin;   Drug: Irinotecan;   Radiation: External Beam Radiation Therapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years